Jennie M Melham Memorial Medical Center | |
145 Memorial Drive, Broken Bow, Nebraska 68822 | |
(308) 872-4100 | |
Name | Jennie M Melham Memorial Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 145 Memorial Drive, Broken Bow, Nebraska |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 281365 |
NPI Number | 1538232244 |
Organization Name | JENNIE M MELHAM MEMORIAL MEDICAL CENTER INC |
Address | 145 Memorial Dr, Broken Bow, NE 68822 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 308-872-4100 |
News Archive
The New York Times: "As health care legislation moves toward a crucial airing in the Senate, the White House is facing a growing revolt from some Democrats and analysts who say the bills Congress is considering do not fulfill President Obama's promise to slow the runaway rise in health care spending. ... The debate underscores a fundamental tension inside the White House between cost-containment idealists and pragmatists."
A new study has found that exposure to bright light before bed time inhibits the production of sleep-promoting hormone, melatonin, in preschoolers.
VTT printed the paper with antibodies that react to the sample. The test result can be read in the form of a line, for example, which either does or does not appear depending on the sample - just like in the pregnancy tests already familiar to consumers. It is also possible to print instructional images or text, for example, either on or alongside the test.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.
› Verified 2 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
The New York Times: "As health care legislation moves toward a crucial airing in the Senate, the White House is facing a growing revolt from some Democrats and analysts who say the bills Congress is considering do not fulfill President Obama's promise to slow the runaway rise in health care spending. ... The debate underscores a fundamental tension inside the White House between cost-containment idealists and pragmatists."
A new study has found that exposure to bright light before bed time inhibits the production of sleep-promoting hormone, melatonin, in preschoolers.
VTT printed the paper with antibodies that react to the sample. The test result can be read in the form of a line, for example, which either does or does not appear depending on the sample - just like in the pregnancy tests already familiar to consumers. It is also possible to print instructional images or text, for example, either on or alongside the test.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.
› Verified 2 days ago
Jennie M Melham Memorial Medical Center Critical Access Hospital Location: 145 Memorial Drive, Broken Bow, Nebraska 68822 Phone: (308) 872-4100 |